Literature DB >> 17544554

Mutations in SH3BP2, the cherubism gene, were not detected in central or peripheral giant cell tumours of the jaw.

Bernadine D Idowu1, Garreth Thomas2, Richard Frow3, Timothy C Diss4, Adrienne M Flanagan5.   

Abstract

Giant cell granulomas of the jaw (GCGJ) are non-familial, generally unilateral osteoclast-rich lesions that are histopathologically indistinguishable from cherubism. Cherubism is an autosomal dominant disease that is characterised by bilateral radiolucencies of the jaw, and caused by mutations that occur in SH3BP2 exon 10. The aim of the study was to screen lesional GCGJ tissue for SH3BP2 mutations. Lesional mononuclear stromal or spindle cells were microdissected from paraffin-embedded tissue from GCGJ, and DNA was then extracted and sequenced for SH3BP2 mutations associated with cherubism. No mutations were detected in 26 GCGJ (15 central, 11 peripheral), which indicated that people with GCGJ do not harbour cherubism-related germline SH3BP2 mutations, and that GCGJ do not harbour somatic SH3BP2 mutations. This suggests that cherubism and GCGJ arise on a different genetic background, and therefore detection of SH3BP2 mutations can be a useful means of distinguishing between them.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17544554     DOI: 10.1016/j.bjoms.2007.04.014

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  11 in total

1.  SOS1 and PTPN11 mutations in five cases of Noonan syndrome with multiple giant cell lesions.

Authors:  Claire Beneteau; Hélène Cavé; Anne Moncla; Nathalie Dorison; Arnold Munnich; Alain Verloes; Bruno Leheup
Journal:  Eur J Hum Genet       Date:  2009-04-08       Impact factor: 4.246

2.  Role of osteoclasts in oral homeostasis and jawbone diseases.

Authors:  Maiko Omi; Yuji Mishina
Journal:  Oral Sci Int       Date:  2020-07-21

Review 3.  Benefits of molecular pathology in the diagnosis of musculoskeletal disease : Part II of a two-part review: bone tumors and metabolic disorders.

Authors:  Adrienne M Flanagan; David Delaney; Paul O'Donnell
Journal:  Skeletal Radiol       Date:  2009-08-11       Impact factor: 2.199

4.  Neurofibromatosis Type 1 With Cherubism-like Phenotype, Multiple Osteolytic Bone Lesions of Lower Extremities, and Alagille-syndrome: Case Report With Literature Survey.

Authors:  Reinhard E Friedrich; Jozef Zustin; Andreas M Luebke; Thorsten Rosenbaum; Martin Gosau; Christian Hagel; Felix K Kohlrusch; Ilse Wieland; Martin Zenker
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

5.  Cherubism combined with epilepsy, mental retardation and gingival fibromatosis (Ramon syndrome): a case report.

Authors:  J Suhanya; Chakshu Aggarwal; Khadijah Mohideen; S Jayachandran; I Ponniah
Journal:  Head Neck Pathol       Date:  2009-12-11

Review 6.  Aggressive giant cell granuloma of the jaws treated with interferon alpha: a report of two cases.

Authors:  J E O'Connell; G J Kearns
Journal:  Ir J Med Sci       Date:  2012-10-26       Impact factor: 1.568

7.  Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features.

Authors:  Falk Wehrhan; Peter Hyckel; Jutta Ries; Phillip Stockmann; Emeka Nkenke; Karl A Schlegel; Friedrich W Neukam; Kerstin Amann
Journal:  J Transl Med       Date:  2010-10-13       Impact factor: 5.531

Review 8.  Insight into the pathogenesis and nature of Central Giant Cell Lesions of the Jaws.

Authors:  Paul-Charles Edwards
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-03-01

Review 9.  Giant cell lesions of the craniofacial bones.

Authors:  Adrienne M Flanagan; Paul M Speight
Journal:  Head Neck Pathol       Date:  2014-11-20

10.  A possible case of cherubism in a 17th-century Korean mummy.

Authors:  Israel Hershkovitz; Mark Spigelman; Rachel Sarig; Do-Sun Lim; In Sun Lee; Chang Seok Oh; Hila May; Elisabetta Boaretto; Yi-Suk Kim; Soong Deok Lee; Nathan Peled; Myeung Ju Kim; Talya Toledano; Gila Kahila Bar-Gal; Dong Hoon Shin
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.